RIAS
BIIB icon

Rachor Investment Advisory Services’s Biogen BIIB Stock Holding History

Rachor Investment Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$184 – 234
2026
Q1 		$184 Buy
+1
New +$184 ﹤0.01% 441

Other funds holding BIIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rachor Investment Advisory Services's BIIB Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Biogen (BIIB) in Q2 2026, closing a stake of 1 share — an estimated $184 sold.

Rachor Investment Advisory Services first reported a position in BIIB in Q1 2026 and held it in 1 quarter. The position peaked at $184 in Q1 2026. 525 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 1 Biogen share in Q2 2026, an estimated $184.
  • Rachor Investment Advisory Services first reported a position in Biogen in Q1 2026 and held it in 1 quarter.
  • Rachor Investment Advisory Services's Biogen position peaked at $184 in Q1 2026.
  • 525 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.